Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of PY314 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)
- Status
- UNKNOWN
- Phase
- PHASE2
Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC
- Status
- COMPLETED
- Phase
- PHASE2
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE3
ImmunoBreast - A Phase Ib Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Multicenter Cancer Biospecimen Collection Study
- Status
- RECRUITING
- Phase
- N/A
Maintenance Treatment With Eribulin Mesylate Versus Observation in Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2